Akebia Therapeutics Inc. (AKBA)
NASDAQ: AKBA
· Real-Time Price · USD
3.67
0.03 (0.82%)
At close: Jun 24, 2025, 3:59 PM
3.73
1.47%
After-hours: Jun 24, 2025, 07:31 PM EDT
0.82% (1D)
| Bid | 3.65 |
| Market Cap | 965.19M |
| Revenue (ttm) | 184.91M |
| Net Income (ttm) | -45.31M |
| EPS (ttm) | -0.21 |
| PE Ratio (ttm) | -17.5 |
| Forward PE | 51.86 |
| Analyst | Buy |
| Ask | 3.75 |
| Volume | 4,382,690 |
| Avg. Volume (20D) | 5,020,037 |
| Open | 3.72 |
| Previous Close | 3.64 |
| Day's Range | 3.64 - 3.84 |
| 52-Week Range | 0.80 - 4.08 |
| Beta | 0.84 |
About AKBA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AKBA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AKBA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Akebia Therapeutics Inc. is scheduled to release its earnings on Aug 7, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+6.5%
Akebia Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
3 months ago
-28.17%
Akebia Therapeutics shares are trading lower after the company announced the pricing of a $50 million offering of 25 million common shares at $2/share.
1 month ago · seekingalpha.com
Akebia Therapeutics, Inc. (AKBA) Q1 2025 Earnings Call TranscriptAkebia Therapeutics, Inc. (NASDAQ:AKBA ) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Company Participants Mercedes Carrasco - Senior Director of Investor Relations John Butler - Chief Exec...
